Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

The Lancet

Volumn 374, Issue 9693, 2009, Pages 893-902

  O'Brien, Katherine L ^a   Wolfson, Lara J ^b   Watt, James P ^a   Henkle, Emily ^a   Deloria Knoll, Maria ^a   McCall, Natalie ^a   Lee, Ellen ^a   Mulholland, Kim ^c   Levine, Orin S ^a   Cherian, Thomas ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PNEUMOCOCCUS VACCINE;

ARTICLE; CAUSE OF DEATH; CHILD; CHILDHOOD MORTALITY; CONTROLLED STUDY; FUNDING; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MENINGITIS; MORBIDITY; PRESCHOOL CHILD; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; WORLD HEALTH ORGANIZATION;

EID: 69949111769     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61204-6     Document Type: Article

References (40)

1. WHO. Report of a meeting on priorities for pneumococcal and Haemophilus influenzae type b (Hib) vaccine development and introduction. Geneva, February 9-12, 1999. WHO/V&B/01.14. http://www.who.int/vaccines-documents/DoxGen/H4-Inno.htm (accessed July 30, 2009).
2. WHO. Pneumococcal vaccines. Wkly Epidemiol Rec 78 (2003) 110-119
3. WHO. Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Wkly Epidemiol Rec 82 (2007) 93-104
4. Deloria-Knoll M., O'Brien K.L., Henkle E., et al. Global literature review of Haemophilus influenzae type b and Streptococcus pneumoniae invasive disease among children less than five years of age, 1980-2005. http://whqlibdoc.who.int/hq/2009/WHO_IVB_09.02_eng.pdf (accessed July 30, 2009).
5. Shibuya K., Scheele S., and Boerma T. Health statistics: time to get serious. Bull World Health Organ 83 (2005) 722
6. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Contr Clin Trials 7 (1986) 177-188
7. UN Population Division. World Population Prospects. http://www.un.org/esa/population/publications/WPP2004/WPP2004_Vol3_Final/Preface_TOC_ExpNotes.pdf (accessed July 30, 2009).
8. UNICEF. Percentage of under fives with suspected pneumonia taken to appropriate health provider. http://www.childinfo.org/pneumonia_countrydatacare.php (accessed Feb 25, 2009).
9. WHO/UNICEF. Estimates of national immunization coverage. http://www.who.int/immunization_monitoring/routine/immunization_coverage/en/index4.html (accessed Feb 25, 2009).
10. Bliss S.J., O'Brien K.L., Janoff E., et al. The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease. Lancet Infect Dis 8 (2007) 67-80
11. Rudan I., Boschi-Pinto C., Biloglav Z., Mulholland K., and Campbell H. The epidemiology and etiology of childhood pneumonia. Bull World Health Organ 86 (2008) 408-416
12. WHO. The global burden of disease 2004 update. http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf (accessed March 1, 2009).
13. Black S., Shinefied H., Ling S., et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J 21 (2002) 810-815
14. Hansen J., Black S., Shinefield H., et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs. Pediatr Infect Dis J 25 (2006) 779-781
15. Klugman K.P., Madhi S.A., Huebner R.E., Kohberger R., Mbelle N., and Pierce N. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 349 (2003) 1341-1348
16. Cutts F., Zaman S., Enwere G., et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomized, double-blind, placebo-controlled trial. Lancet 365 (2005) 1139-1146
17. Lucero M., Nohynek H., Williams G., et al. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than two years of age in the Philippines: a randomized, double-blind, placebo-controlled trial. Pediatr Infect Dis J 28 (2009) 455-462
18. Cherian T., Mulholland E.K., Carlin J.B., et al. Standardized interpretation of paediatric chest radiographs for the interpretation of pediatric pneumonia in epidemiologic studies. Bull World Health Organ 83 (2005) 353-359
19. Bryce J., Boschi-Pinto C., Shibuya K., Black R.E., and WHO Child Health Epidemiology Reference Group. WHO estimates of the causes of death in children. Lancet 365 (2005) 1147-1152
20. Brooks W.A., Breiman R.F., Goswami D., et al. Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh. Am J Trop Med Hyg 77 (2007) 795-801
21. Lawn J.E., Cousens S., Zupan J., and Lancet Neonatal Survival Steering Team. 4 million neonatal deaths: When? Where? Why?. Lancet 365 (2005) 891-900
22. Williams B.G., Gouws E., Boschi-Pinto C., Bryce J., and Dye C. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis 2 (2002) 25-32
23. WHO. The world health report 2005. Make every mother and child count. http://www.who.int/whr/2005/en/index.html (accessed July 15, 2009).
24. Lawn J.E., Wilczynska-Ketende K., and Cousens S.N. Estimating the causes of 4 million neonatal deaths in the year 2000. Int J Epidemiol 35 (2006) 706-718
25. The WHO Young Infants Study Group. Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study. Pediatr Infect Dis J 18 suppl (1999) S17-S22
26. Mulholland K. Strategies for the control of pneumococcal disease. Vaccine 17 (1999) S79-S84
27. Constenla D., Gomez E., de la Hoz F.P., et al. The burden of pneumococcal disease and the cost effectiveness of a pneumococcal vaccine in Latin America and the Caribbean: a review of the evidence and a preliminary economic analysis (2007). http://www.sabin.org/digital-library/publication/burden-pneumococcal-disease-and-cost-effectiveness-pneumococcal-vaccine (accessed Aug 7, 2009).
28. Cherian T., Lalitha M.K., Manoharan A., Thomas K., Yolken R.H., and Steinhoff M.C. PCR-Enzyme immunoassay for detection of Streptococcus pneumoniae DNA in cerebrospinal fluid samples from patients with culture-negative meningitis. J Clin Microbiol 36 (1998) 3605-3608
29. Moïsi JC, Saha SK, Falade AG, et al. Enhanced diagnosis of pneumococcal meningitis using the Binax NOW® S. pneumoniae immuno-chromatographic test: a multi-site study. 6th International Symposium on Pneumococci and Pneumococcal Disease. June 8-12, 2008. Iceland. Abstract number S04-O2.
30. Berkley J.A., Lowe B.S., Mwangi I., et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 352 (2005) 39-47
31. WHO. Vital registration data reported to WHO by member states. http://www.who.int/healthinfo/morttables/en/index.html (accessed March 1, 2009).
32. Morris S.S., Black R.E., and Tomaskovic L. Predicting the distribution of under-five deaths by cause in countries without adequate vital registration systems. Int J Epidemiol 32 (2003) 1041-1051
33. WHO. World Health Statistics 2006 (2006), World Health Organization, Geneva. http://www.who.int/whosis/whostat2006/en/index.html (accessed Aug 7, 2009).
34. Watt J. Burden of Haemophilus influenzae b (Hib) disease study-Mongolia (2004), World Health Organization Report No: WP/ICP/EPI/5.2/001/XZ/04:2004.
35. Tall F.R., Elola A., Prazuck T., Traore A., Nacro B., and Vincent-Ballereau F. Haemophilus influenzae meningitis in a hospital in Burkina-Faso. Medecine et Maladies Infectieuses 22 (1992) 1173-1177
36. du Chatelet I.P., Traore Y., Gessner B.D., et al. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Clin Infect Dis 40 (2005) 17-25
37. Bernard-Bonnin A.C., and Ekoe T. Purulent meningitis in children in Yaounde: epidemiological and prognostic aspects. Ann Soc Belg Med Trop 65 (1985) 59-68
38. CDC. Progress in introduction of pneumococcal conjugate vaccine-worldwide, 2000-2008. Morb Mortal Wkly Rep 57 (2008) 1148-1151
39. Levine O.S., O'Brien K.L., Knoll M., et al. Time to begin pneumococcal vaccination in developing countries. Lancet 367 (2006) 1880-1882
40. UN. General Assembly, 56th session. Road map towards the implementation of the United Nations millennium declaration: report of the Secretary-General (UN document no. A/56/326) (2001), United Nations, New York